Pulmonary-renal syndrome with a focus on Anti-GBM disease

Seminars in Respiratory and Critical Care Medicine

Volumn 32, Issue 3, 2011, Pages 328-334

  Sanders, Jan Stephan F ^a   Rutgers, Abraham ^a   Stegeman, Coen A ^a   Kallenberg, Cees G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ANCA; Anti GBM; Goodpasture; rapidly progressive glomerulonephritis; vasculitis

Indexed keywords

AZATHIOPRINE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; HLA DR15 ANTIGEN; HLA DR4 ANTIGEN; HLA DR7 ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELOPEROXIDASE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; PROTEINASE 3 ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ANCA ASSOCIATED VASCULITIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CORTICOSTEROID THERAPY; DIAGNOSTIC VALUE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; LUNG INFILTRATE; MICROSCOPIC POLYANGIITIS; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; THORAX RADIOGRAPHY; WEGENER GRANULOMATOSIS;

ACUTE KIDNEY INJURY; ADRENAL CORTEX HORMONES; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; CYCLOPHOSPHAMIDE; HEMORRHAGE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PLASMAPHERESIS; PULMONARY ALVEOLI; RESPIRATORY INSUFFICIENCY;

EID: 79959237572     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0031-1279829     Document Type: Article

References (48)

1. Goodpasture E W. Landmark publication from the American Journal of the Medical Sciences: the significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci 2009 338 2 148-151
2. Stanton M C., Tange J D. Goodpasture's syndrome (pulmonary haemorrhage associated with glomerulonephritis). Australas Ann Med 1958 7 2 132-144
3. Lerner R A., Glassock R J., Dixon F J. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 1967 126 6 989-1004
4. Gallagher H, Kwan J T., Jayne D R. Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 2002 39 1 42-47 (Pubitemid 34062494)
5. Cortese G, Nicali R, Placido R, Gariazzo G, Anr P. Radiological aspects of diffuse alveolar haemorrhage. Radiol Med (Torino) 2008 113 1 16-28 (Pubitemid 351387212)
6. Bowley N B., Steiner R E., Chin W S. The chest X-ray in antiglomerular basement membrane antibody disease (Goodpasture's syndrome). Clin Radiol 1979 30 4 419-429 (Pubitemid 9207926)
7. Perazella M A., Coca S G., Kanbay M, Brewster U C., Parikh C R. Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 2008 3 6 1615-1619
8. O'Neill W C. Sonographic evaluation of renal failure. Am J Kidney Dis 2000 35 6 1021-1038 (Pubitemid 30354403)
9. Niles J L., Böttinger E P., Saurina G R. et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996 156 4 440-445
10. Saxena R, Bygren P, Arvastson B, Wieslander J. Circulating autoantibodies as serological markers in the differential diagnosis of pulmonary renal syndrome. J Intern Med 1995 238 2 143-152
11. Couser W G. Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 1988 11 6 449-464
12. Jennette J C., Falk R J., Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994 37 2 187-192 (Pubitemid 24065492)
13. Davies D J., Moran J E., Niall J F., Ryan G B. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J (Clin Res Ed) 1982 285 6342 606 (Pubitemid 12042688)
14. Savige J, Davies D, Falk R J., Jennette J C., Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 2000 57 3 846-862 (Pubitemid 30434775)
15. Savige J, Gillis D, Benson E et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 1999 111 4 507-513 (Pubitemid 29153147)
16. Hagen E C., Daha M R., Hermans J et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998 53 3 743-753 (Pubitemid 28124291)
17. Chen M, Kallenberg C G., Zhao M H. ANCA-negative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol 2009 5 6 313-318
18. Reinhold-Keller E, de Groot K, Holl-Ulrich K et al. Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA): a report of 3 cases and a review of the literature. Clin Exp Rheumatol 2001 19 5 541-549 (Pubitemid 32894603)
19. Jones D A., Jennette J C., Falk R J. Goodpasture's syndrome revisited: a new perspective on glomerulonephritis and alveolar hemorrhage. N C Med J 1990 51 8 411-415
20. Hudson B G., Kalluri R, Gunwar S, Noelken M E., Mariyama M, Reeders S T. Molecular characteristics of the Goodpasture autoantigen. Kidney Int 1993 43 1 135-139 (Pubitemid 23167457)
21. Salama A D., Dougan T, Levy J B. et al. Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis 2002 39 6 1162-1167 (Pubitemid 34591930)
22. Short A K., Esnault V L., Lockwood C M. Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis 1995 26 3 439-445
23. Rutgers A, Damoiseaux J, Roozendaal C, Limburg P C., Stegeman C A., Tervaert J W. ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis. J Clin Immunol 2004 24 4 435-440 (Pubitemid 39005576)
24. Tervaert J W., Damoiseaux J. Fifty years of antineutrophil cytoplasmic antibodies (ANCA) testing: do we need to revise the international consensus statement on testing and reporting on ANCA? APMIS Suppl 2009 June 127 55-59
25. Kaul R, Johnson K, Scholz H, Marr G. Performance of the BioPlex 2200 Autoimmune Vasculitis kit. Autoimmun Rev 2009 8 3 224-227
26. Meyers K E., Allen J, Gehret J et al. Human antiglomerular basement membrane autoantibody disease in XenoMouse II. Kidney Int 2002 61 5 1666-1673 (Pubitemid 34437920)
27. Cui Z, Zhao M H. Avidity of anti-glomerular basement membrane autoantibodies was associated with renal pathological damage [in Chinese]. Zhonghua Yi Xue Za Zhi 2005 85 13 903-907 (Pubitemid 41057095)
28. Hudson B G., Tryggvason K, Sundaramoorthy M, Neilson E G. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003 348 25 2543-2556 (Pubitemid 36706542)
29. Salama A D., Chaudhry A N., Holthaus K A. et al. Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int 2003 64 5 1685-1694 (Pubitemid 37323697)
30. Wu J, Hicks J, Borillo J, Glass W F. II, Lou Y H. CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. J Clin Invest 2002 109 4 517-524 (Pubitemid 34171783)
31. Zou J, Hannier S, Cairns L S. et al. Healthy individuals have Goodpasture autoantigen-reactive T cells. J Am Soc Nephrol 2008 19 2 396-404 (Pubitemid 351240661)
32. Wolf D, Hochegger K, Wolf A M. et al. CD4+ CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 2005 16 5 1360-1370 (Pubitemid 41716520)
33. Phelps R G., Rees A J. The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity. Kidney Int 1999 56 5 1638-1653 (Pubitemid 29518164)
34. Johnson J P., Moore J Jr, Austin H A. III, Balow J E., Antonovych T T., Wilson C B. Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore) 1985 64 4 219-227 (Pubitemid 16247105)
35. Salama A D., Levy J B., Lightstone L, Pusey C D. Goodpasture's disease. Lancet 2001 358 9285 917-920 (Pubitemid 32900581)
36. Levy J B., Turner A N., Rees A J., Pusey C D. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 2001 134 11 1033-1042 (Pubitemid 32488657)
37. Hirayama K, Yamagata K, Kobayashi M, Koyama A. Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan. Clin Exp Nephrol 2008 12 5 339-347
38. Jayne D R., Gaskin G, Rasmussen N et al, European Vasculitis Study Group. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 2007 18 7 2180-2188 (Pubitemid 47041083)
39. Laczika K, Knapp S, Derfler K, Soleiman A, Hörl W H., Druml W. Immunoadsorption in Goodpasture's syndrome. Am J Kidney Dis 2000 36 2 392-395 (Pubitemid 30485848)
40. Arzoo K, Sadeghi S, Liebman H A. Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab). Ann Rheum Dis 2002 61 10 922-924
41. García-Cantón C, Toledo A, Palomar R et al. Goodpasture's syndrome treated with mycophenolate mofetil. Nephrol Dial Transplant 2000 15 6 920-922 (Pubitemid 30312025)
42. Deegens J K., Artz M A., Hoitsma A J., Wetzels J F. Outcome of renal transplantation in patients with pauci-immune small vessel vasculitis or anti-GBM disease. Clin Nephrol 2003 59 1 1-9 (Pubitemid 36150458)
43. Cameron J S. Glomerulonephritis in renal transplants. Transplantation 1982 34 5 237-245 (Pubitemid 13253418)
44. Sauter M, Schmid H, Anders H J., Heller F, Weiss M, Sitter T. Loss of a renal graft due to recurrence of anti-GBM disease despite rituximab therapy. Clin Transplant 2009 23 1 132-136
45. Khandelwal M, McCormick B B., Lajoie G, Sweet J, Cole E, Cattran D C. Recurrence of anti-GBM disease 8 years after renal transplantation. Nephrol Dial Transplant 2004 19 2 491-494 (Pubitemid 38196007)
46. Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert J W. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis 2005 46 2 253-262 (Pubitemid 41040353)
47. Bosch X, Mirapeix E, Font J et al. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol 1991 36 3 107-113
48. Levy J B., Hammad T, Coulthart A, Dougan T, Pusey C D. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 2004 66 4 1535-1540 (Pubitemid 39298387)